Food Confectioners
Compare Stocks
4 / 10Stock Comparison
MDLZ vs HSY vs CPB vs TR
Revenue, margins, valuation, and 5-year total return — side by side.
Food Confectioners
Packaged Foods
Food Confectioners
MDLZ vs HSY vs CPB vs TR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Food Confectioners | Food Confectioners | Packaged Foods | Food Confectioners |
| Market Cap | $78.76B | $37.48B | $6.23B | $3.18B |
| Revenue (TTM) | $39.30B | $11.99B | $10.04B | $733M |
| Net Income (TTM) | $2.61B | $1.09B | $550M | $100M |
| Gross Margin | 28.8% | 34.8% | 29.3% | 35.5% |
| Operating Margin | 9.4% | 14.1% | 12.1% | 14.0% |
| Forward P/E | 20.1x | 22.0x | 9.6x | 22.5x |
| Total Debt | $22.40B | $5.40B | $7.21B | $14M |
| Cash & Equiv. | $2.13B | $926M | $132M | $128M |
MDLZ vs HSY vs CPB vs TR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Mondelez Internatio… (MDLZ) | 100 | 117.7 | +17.7% |
| The Hershey Company (HSY) | 100 | 136.3 | +36.3% |
| Campbell Soup Compa… (CPB) | 100 | 41.0 | -59.0% |
| Tootsie Roll Indust… (TR) | 100 | 145.9 | +45.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MDLZ vs HSY vs CPB vs TR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MDLZ lags the leaders in this set but could rank higher in a more targeted comparison.
HSY is the clearest fit if your priority is long-term compounding.
- 141.9% 10Y total return vs TR's 77.5%
- 2.9% yield, 34-year raise streak, vs CPB's 7.3%
CPB is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta -0.02, yield 7.3%
- Rev growth 6.4%, EPS growth 6.3%, 3Y rev CAGR 6.2%
- Beta -0.02, yield 7.3%, current ratio 0.77x
- 6.4% revenue growth vs TR's 1.3%
TR carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta -0.03, Low D/E 1.5%, current ratio 3.27x
- 13.7% margin vs CPB's 5.5%
- Lower D/E ratio (1.5% vs 184.7%)
- +32.9% vs CPB's -36.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.4% revenue growth vs TR's 1.3% | |
| Value | Lower P/E (9.6x vs 22.5x) | |
| Quality / Margins | 13.7% margin vs CPB's 5.5% | |
| Stability / Safety | Lower D/E ratio (1.5% vs 184.7%) | |
| Dividends | 2.9% yield, 34-year raise streak, vs CPB's 7.3% | |
| Momentum (1Y) | +32.9% vs CPB's -36.8% | |
| Efficiency (ROA) | 8.3% ROA vs CPB's 3.7%, ROIC 9.8% vs 9.1% |
MDLZ vs HSY vs CPB vs TR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MDLZ vs HSY vs CPB vs TR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TR leads in 3 of 6 categories
HSY leads 1 • CPB leads 1 • MDLZ leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HSY leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MDLZ is the larger business by revenue, generating $39.3B annually — 53.7x TR's $733M. TR is the more profitable business, keeping 13.7% of every revenue dollar as net income compared to CPB's 5.5%. On growth, HSY holds the edge at +10.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $39.3B | $12.0B | $10.0B | $733M |
| EBITDAEarnings before interest/tax | $4.9B | $2.0B | $1.6B | $122M |
| Net IncomeAfter-tax profit | $2.6B | $1.1B | $550M | $100M |
| Free Cash FlowCash after capex | $2.6B | $2.2B | $919M | $96M |
| Gross MarginGross profit ÷ Revenue | +28.8% | +34.8% | +29.3% | +35.5% |
| Operating MarginEBIT ÷ Revenue | +9.4% | +14.1% | +12.1% | +14.0% |
| Net MarginNet income ÷ Revenue | +6.6% | +9.1% | +5.5% | +13.7% |
| FCF MarginFCF ÷ Revenue | +6.6% | +18.1% | +9.2% | +13.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.2% | +10.6% | -4.5% | +1.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.7% | +93.6% | -17.2% | +21.9% |
Valuation Metrics
CPB leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 10.4x trailing earnings, CPB trades at a 76% valuation discount to HSY's 42.6x P/E. On an enterprise value basis, CPB's 7.5x EV/EBITDA is more attractive than HSY's 29.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $78.8B | $37.5B | $6.2B | $3.2B |
| Enterprise ValueMkt cap + debt − cash | $99.0B | $42.0B | $13.3B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 32.47x | 42.61x | 10.40x | 30.84x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.07x | 21.99x | 9.58x | 22.47x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.65x |
| EV / EBITDAEnterprise value multiple | 19.90x | 28.96x | 7.45x | 25.14x |
| Price / SalesMarket cap ÷ Revenue | 2.04x | 3.21x | 0.61x | 4.34x |
| Price / BookPrice ÷ Book value/share | 3.08x | 8.11x | 1.61x | 3.27x |
| Price / FCFMarket cap ÷ FCF | 24.35x | 21.43x | 8.84x | 32.96x |
Profitability & Efficiency
TR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HSY delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $10 for MDLZ. TR carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPB's 1.85x. On the Piotroski fundamental quality scale (0–9), CPB scores 7/9 vs MDLZ's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.0% | +23.7% | +14.0% | +11.0% |
| ROA (TTM)Return on assets | +3.7% | +8.0% | +3.7% | +8.3% |
| ROICReturn on invested capital | +6.0% | +11.5% | +9.1% | +9.8% |
| ROCEReturn on capital employed | +7.3% | +14.4% | +11.4% | +9.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.87x | 1.17x | 1.85x | 0.01x |
| Net DebtTotal debt minus cash | $20.3B | $4.5B | $7.1B | -$114M |
| Cash & Equiv.Liquid assets | $2.1B | $926M | $132M | $128M |
| Total DebtShort + long-term debt | $22.4B | $5.4B | $7.2B | $14M |
| Interest CoverageEBIT ÷ Interest expense | 10.01x | 7.99x | 3.14x | 276.65x |
Total Returns (Dividends Reinvested)
TR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TR five years ago would be worth $16,431 today (with dividends reinvested), compared to $5,820 for CPB. Over the past 12 months, TR leads with a +32.9% total return vs CPB's -36.8%. The 3-year compound annual growth rate (CAGR) favors TR at 7.9% vs CPB's -22.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.3% | +2.2% | -21.7% | +19.6% |
| 1-Year ReturnPast 12 months | -6.6% | +14.3% | -36.8% | +32.9% |
| 3-Year ReturnCumulative with dividends | -13.8% | -27.1% | -53.5% | +25.5% |
| 5-Year ReturnCumulative with dividends | +14.0% | +23.7% | -41.8% | +64.3% |
| 10-Year ReturnCumulative with dividends | +69.9% | +141.9% | -43.8% | +77.5% |
| CAGR (3Y)Annualised 3-year return | -4.8% | -10.0% | -22.5% | +7.9% |
Risk & Volatility
TR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
TR is the less volatile stock with a -0.03 beta — it tends to amplify market swings less than MDLZ's 0.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TR currently trades 93.8% from its 52-week high vs CPB's 57.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.06x | -0.03x | -0.02x | -0.03x |
| 52-Week HighHighest price in past year | $71.15 | $239.48 | $36.16 | $45.06 |
| 52-Week LowLowest price in past year | $51.20 | $150.04 | $19.76 | $29.78 |
| % of 52W HighCurrent price vs 52-week peak | +86.2% | +77.2% | +57.8% | +93.8% |
| RSI (14)Momentum oscillator 0–100 | 66.9 | 28.4 | 39.0 | 46.3 |
| Avg Volume (50D)Average daily shares traded | 9.1M | 1.7M | 9.2M | 126K |
Analyst Outlook
Evenly matched — HSY and CPB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MDLZ as "Buy", HSY as "Hold", CPB as "Hold". Consensus price targets imply 23.5% upside for CPB (target: $26) vs 9.2% for MDLZ (target: $67). For income investors, CPB offers the higher dividend yield at 7.32% vs TR's 0.85%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | — |
| Price TargetConsensus 12-month target | $67.00 | $226.29 | $25.83 | — |
| # AnalystsCovering analysts | 41 | 35 | 29 | — |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +2.9% | +7.3% | +0.8% |
| Dividend StreakConsecutive years of raises | 12 | 34 | 1 | 1 |
| Dividend / ShareAnnual DPS | $1.92 | $5.34 | $1.53 | $0.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | 0.0% | +1.0% | +0.2% |
TR leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). HSY leads in 1 (Income & Cash Flow). 1 tied.
MDLZ vs HSY vs CPB vs TR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MDLZ or HSY or CPB or TR a better buy right now?
For growth investors, Campbell Soup Company (CPB) is the stronger pick with 6.
4% revenue growth year-over-year, versus 1. 3% for Tootsie Roll Industries, Inc. (TR). Campbell Soup Company (CPB) offers the better valuation at 10. 4x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Mondelez International, Inc. (MDLZ) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MDLZ or HSY or CPB or TR?
On trailing P/E, Campbell Soup Company (CPB) is the cheapest at 10.
4x versus The Hershey Company at 42. 6x. On forward P/E, Campbell Soup Company is actually cheaper at 9. 6x.
03Which is the better long-term investment — MDLZ or HSY or CPB or TR?
Over the past 5 years, Tootsie Roll Industries, Inc.
(TR) delivered a total return of +64. 3%, compared to -41. 8% for Campbell Soup Company (CPB). Over 10 years, the gap is even starker: HSY returned +141. 9% versus CPB's -43. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MDLZ or HSY or CPB or TR?
By beta (market sensitivity over 5 years), Tootsie Roll Industries, Inc.
(TR) is the lower-risk stock at -0. 03β versus Mondelez International, Inc. 's 0. 06β — meaning MDLZ is approximately -332% more volatile than TR relative to the S&P 500. On balance sheet safety, Tootsie Roll Industries, Inc. (TR) carries a lower debt/equity ratio of 1% versus 185% for Campbell Soup Company — giving it more financial flexibility in a downturn.
05Which is growing faster — MDLZ or HSY or CPB or TR?
By revenue growth (latest reported year), Campbell Soup Company (CPB) is pulling ahead at 6.
4% versus 1. 3% for Tootsie Roll Industries, Inc. (TR). On earnings-per-share growth, the picture is similar: Tootsie Roll Industries, Inc. grew EPS 16. 1% year-over-year, compared to -60. 3% for The Hershey Company. Over a 3-year CAGR, MDLZ leads at 7. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MDLZ or HSY or CPB or TR?
Tootsie Roll Industries, Inc.
(TR) is the more profitable company, earning 13. 7% net margin versus 5. 9% for Campbell Soup Company — meaning it keeps 13. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TR leads at 14. 0% versus 9. 4% for MDLZ. At the gross margin level — before operating expenses — TR leads at 35. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MDLZ or HSY or CPB or TR more undervalued right now?
On forward earnings alone, Campbell Soup Company (CPB) trades at 9.
6x forward P/E versus 22. 5x for Tootsie Roll Industries, Inc. — 12. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CPB: 23. 5% to $25. 83.
08Which pays a better dividend — MDLZ or HSY or CPB or TR?
All stocks in this comparison pay dividends.
Campbell Soup Company (CPB) offers the highest yield at 7. 3%, versus 0. 8% for Tootsie Roll Industries, Inc. (TR).
09Is MDLZ or HSY or CPB or TR better for a retirement portfolio?
For long-horizon retirement investors, The Hershey Company (HSY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
03), 2. 9% yield, +141. 9% 10Y return). Both have compounded well over 10 years (HSY: +141. 9%, CPB: -43. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MDLZ and HSY and CPB and TR?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MDLZ is a mid-cap income-oriented stock; HSY is a mid-cap quality compounder stock; CPB is a small-cap deep-value stock; TR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.